Caris Life Sciences, Inc.
Biotechnology firm using molecular science and AI for precision cancer care.
CAI | US
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 750 W JOHN CARPENTER FREEWAY, 75039 IRVING
- Industry:
- Other human health activities
Description
Caris Life Sciences is a biotechnology company specializing in precision medicine to revolutionize cancer care. The company combines advanced molecular science with artificial intelligence to analyze the molecular complexity of disease. Its core services include comprehensive molecular profiling through whole exome and whole transcriptome sequencing of DNA and RNA from tissue and blood. These analyses provide physicians and patients with critical insights for personalized therapy selection, disease detection, and treatment monitoring. A key offering, Caris Assure®, is a pan-cancer assay that utilizes a circulating Nucleic Acid Sequencing (cNAS) approach from a blood sample. By decoding a patient's unique molecular information, Caris aims to improve patient outcomes and transform oncology treatment.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Caris Life Sciences, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Caris Life Sciences, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Caris Life Sciences, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
